Literature DB >> 33732298

Long non-coding RNA small nucleolar RNA host gene 1 knockdown suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating microRNA-424-5p/FGF2 in vitro.

Zhuokai Li1, Xiaohe Wang2, Shuofu Liang3.   

Abstract

The aim of the present study was to clarify the effect of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) on the proliferation, migration and invasion of osteosarcoma (OS) cells and to explore the potential underlying mechanisms. The expression levels of SNHG1, microRNA (miR)-424-5p and fibroblast growth factor 2 (FGF2) in OS tissues and cells were detected using reverse transcription-quantitative polymerase chain reaction. OS cell proliferation, migration and invasion were analysed by MTT, wound healing and Transwell invasion assays, respectively. The targeting relationships between SNHG1 and miR-424-5p, as well as between miR-424-5p and FGF2, were confirmed using RNA-binding protein immunoprecipitation and/or dual-luciferase reporter gene assays. The results demonstrated that the expression levels of SNHG1 and FGF2 were upregulated, whereas the expression of miR-424-5p was downregulated in OS tissues and cells. The silencing of SNHG1 significantly inhibited the proliferation, migration and invasion of OS cells. Additionally, FGF2 was shown to be a target of miR-424-5p, which in turn, was a target of SNHG1. miR-424-5p silencing and FGF2 overexpression both reversed the suppressive effects of SNHG1 knockdown on the proliferation, migration and invasion of OS cells. Thus, the silencing of SNHG1 may inhibit the proliferation, migration and invasion of OS cells by regulating the miR-424-5p/FGF2 axis.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  invasion; microRNA-424-5p; migration; osteosarcoma; proliferation; small nucleolar RNA host gene 1

Year:  2021        PMID: 33732298      PMCID: PMC7903380          DOI: 10.3892/etm.2021.9756

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  35 in total

Review 1.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: correlation with local relapses.

Authors:  P Gazzaniga; O Gandini; A Gradilone; I Silvestri; L Giuliani; M Magnanti; M Gallucci; G Saccani; L Frati; A M Agliano
Journal:  Int J Oncol       Date:  1999-06       Impact factor: 5.650

3.  Acidic and basic fibroblast growth factor expression levels in cervical cancer and their effects on tumor cell proliferation.

Authors:  Q H Zhang; P Xu; Y X Lu; H T Dou
Journal:  Genet Mol Res       Date:  2016-12-02

Review 4.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

5.  miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.

Authors:  Peixin Dong; Ying Xiong; Junming Yue; Sharon J B Hanley; Hidemichi Watari
Journal:  Oncotarget       Date:  2018-05-01

6.  The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.

Authors:  Dan Fei; Guoqing Sui; Yang Lu; Long Tan; Zhao Dongxu; Kewei Zhang
Journal:  J Cell Mol Med       Date:  2018-12-19       Impact factor: 5.310

7.  miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.

Authors:  Jingbang Wu; Beng Yang; Yanpeng Zhang; Xiaode Feng; Bin He; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  Int J Biol Sci       Date:  2019-06-04       Impact factor: 6.580

8.  Long Non-Coding RNA LINC00511 Mediates the Effects of ESR1 on Proliferation and Invasion of Ovarian Cancer Through miR-424-5p and miR-370-5p.

Authors:  Kang Wang; Genhai Zhu; Shan Bao; Shiling Chen
Journal:  Cancer Manag Res       Date:  2019-12-27       Impact factor: 3.989

Review 9.  The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.

Authors:  Bin Zhang; Yan Zhang; Rongzhen Li; Jiazhen Li; Xinchang Lu; Yi Zhang
Journal:  J Orthop Surg Res       Date:  2020-02-13       Impact factor: 2.359

10.  Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase.

Authors:  Xing Hua Long; Jian Hua Mao; Ai Fen Peng; Yang Zhou; Shan Hu Huang; Zhi Li Liu
Journal:  Exp Ther Med       Date:  2013-02-18       Impact factor: 2.447

View more
  1 in total

1.  N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.

Authors:  Kun Yang; Fengyan Wang; Ke Li; Guoxuan Peng; Hua Yang; Hong Xu; Yang Xiang; Hong Sun
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.